推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 近日，省局印發(fā)《江蘇省中藥飲片專項整治工作方案》，從2020年3月至2021年9月，在全省開展為期-年半的中藥飲片專項整治工作，重點針對中藥飲片和制劑生產(chǎn)經(jīng)營領(lǐng)域存在的突出問題，進一步加強中藥飲片質(zhì)量監(jiān)管,督促企業(yè)落實質(zhì)安全主體責任,規(guī)范行業(yè)秩序,嚴厲打擊違法違規(guī)行為,凈化中藥飲片市場秩序。
專項整治圍繞嚴格許可審批、完善藥品標準、強化生產(chǎn)監(jiān)管、規(guī)范經(jīng)營使用行為、加大抽驗力度、嚴懲違法行為六個方面展開。審批環(huán)節(jié)，要嚴格執(zhí)行企業(yè)開辦標準，不得擅自降低開辦條件,嚴把準入關(guān)。生產(chǎn)環(huán)節(jié)，重點整治從非法渠道購進中藥飲片,使用不合格中藥材、中藥飲片投料等違法違規(guī)行為，督促企業(yè)嚴格執(zhí)行GMP、履行上市許可持有人相關(guān)義務。經(jīng)營使用環(huán)節(jié)，重點整治非法生產(chǎn)經(jīng)營中藥飲片，從非法渠道購進中藥飲片等行為，督促經(jīng)營企業(yè)和使用單位加強中藥飲片儲存保管。打擊違法行為方面,加大中藥飲片抽檢力度，強化抽檢的監(jiān)管震懾,重點打擊非法加工、變相生產(chǎn)中藥飲片、從非法渠道購進中藥飲片、出租出借證照等行為,對發(fā)現(xiàn)的違法行為追根溯源、一查到底。
專項整治行動分為動員部署與自查自糾,專項檢查、監(jiān)督抽驗與案件查處，督查總結(jié)三個階段。各級監(jiān)管部門]要成立專項整治工作組織領(lǐng)導機構(gòu)，加強組織領(lǐng)導和統(tǒng)籌協(xié)調(diào);要強化各部門之間的協(xié)同配合，依職權(quán)開展整治工作;要圍繞整治重點，嚴格開展現(xiàn)場.檢查,督促企業(yè)落實主體責任，務求發(fā)現(xiàn)問題、消除隱患、防范風險;要加強督導巡查,確保專項整治工作落到實處，取得實實在在的整治成效。
